ALDH1A3 and prostate carcinoma: GTex data revealed that ALDH1A3 expression is low or absent in nearly all normal tissues while it is enriched in discrete tumor types, including sarcoma, prostate cancer, pancreatic cancer, and melanoma (Figure 5E).